Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 311

1.

A prospective analysis of the preventability of adverse drug reactions reported in Sweden.

Lövborg H, Eriksson LR, Jönsson AK, Bradley T, Hägg S.

Eur J Clin Pharmacol. 2012 Aug;68(8):1183-9. doi: 10.1007/s00228-012-1237-2. Epub 2012 Feb 19.

PMID:
22349466
[PubMed - indexed for MEDLINE]
2.

Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.

Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, Hazell L, Krska J, Lee AJ, McLernon DJ, Murphy E, Shakir S, Watson MC.

Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Review.

PMID:
21545758
[PubMed - indexed for MEDLINE]
Free Article
3.

Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department.

Olivier P, Boulbés O, Tubery M, Lauque D, Montastruc JL, Lapeyre-Mestre M.

Drug Saf. 2002;25(14):1035-44.

PMID:
12408734
[PubMed - indexed for MEDLINE]
4.

Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.

Jose J, Rao PG.

Pharmacol Res. 2006 Sep;54(3):226-33. Epub 2006 May 12.

PMID:
16781163
[PubMed - indexed for MEDLINE]
5.

Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.

Tabali M, Ostermann T, Jeschke E, Witt CM, Matthes H.

J Manag Care Pharm. 2012 Jul-Aug;18(6):427-38.

PMID:
22839683
[PubMed - indexed for MEDLINE]
Free Article
6.

The DoTS classification is a useful way to classify adverse drug reactions: a preliminary study in hospitalized patients.

Calderón-Ospina C, Bustamante-Rojas C.

Int J Pharm Pract. 2010 Aug;18(4):230-5. doi: 10.1111/j.2042-7174.2010.00039.x.

PMID:
20636675
[PubMed - indexed for MEDLINE]
7.

Adverse drug reactions in a pulmonary teaching hospital: incidence, pattern, seriousness, and preventability.

Baniasadi S, Fahimi F.

Curr Drug Saf. 2011 Sep 1;6(4):230-6.

PMID:
22129318
[PubMed - indexed for MEDLINE]
8.

Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients.

Franceschi M, Scarcelli C, Niro V, Seripa D, Pazienza AM, Pepe G, Colusso AM, Pacilli L, Pilotto A.

Drug Saf. 2008;31(6):545-56.

PMID:
18484788
[PubMed - indexed for MEDLINE]
9.

Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.

Aagaard L, Strandell J, Melskens L, Petersen PS, Holme Hansen E.

Drug Saf. 2012 Dec 1;35(12):1171-82. doi: 10.2165/11631940-000000000-00000.

PMID:
23072620
[PubMed - indexed for MEDLINE]
10.

Pharmacovigilance in children in Camagüey Province, Cuba.

Bárzaga Arencibia Z, López Leyva A, Mejías Peña Y, González Reyes AR, Fernández Manzano E, Choonara I.

Eur J Clin Pharmacol. 2012 Jul;68(7):1079-84. doi: 10.1007/s00228-012-1222-9. Epub 2012 Feb 8.

PMID:
22315149
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Drug-related deaths: an analysis of the Italian spontaneous reporting database.

Leone R, Sottosanti L, Luisa Iorio M, Santuccio C, Conforti A, Sabatini V, Moretti U, Venegoni M.

Drug Saf. 2008;31(8):703-13.

PMID:
18636789
[PubMed - indexed for MEDLINE]
12.

Adverse drug reactions & their risk factors among Indian ambulatory elderly patients.

Mandavi, D'Cruz S, Sachdev A, Tiwari P.

Indian J Med Res. 2012 Sep;136(3):404-10.

PMID:
23041733
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre.

Jonville-Béra AP, Saissi H, Bensouda-Grimaldi L, Beau-Salinas F, Cissoko H, Giraudeau B, Autret-Leca E.

Drug Saf. 2009;32(5):429-40. doi: 10.2165/00002018-200932050-00006.

PMID:
19419237
[PubMed - indexed for MEDLINE]
14.

[Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale].

Olivier P, Caron J, Haramburu F, Imbs JL, Jonville-Béra AP, Lagier G, Sgro C, Vial T, Montastruc JL, Lapeyr-Mestre M.

Therapie. 2005 Jan-Feb;60(1):39-45. French.

PMID:
15929472
[PubMed - indexed for MEDLINE]
15.

Evaluation of completeness of suspected adverse drug reaction reports submitted to the mexican national pharmacovigilance centre: a cross-sectional period-prevalence study.

Sánchez-Sánchez B, Altagracia-Martínez M, Kravzov-Jinich J, Moreno-Bonett C, Vázquez-Moreno E, Martínez-Núñez JM.

Drug Saf. 2012 Oct 1;35(10):837-44. doi: 10.2165/11631810-000000000-00000.

PMID:
22924896
[PubMed - indexed for MEDLINE]
16.

Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay.

Hanlon JT, Pieper CF, Hajjar ER, Sloane RJ, Lindblad CI, Ruby CM, Schmader KE.

J Gerontol A Biol Sci Med Sci. 2006 May;61(5):511-5.

PMID:
16720750
[PubMed - indexed for MEDLINE]
17.

Nurses are increasingly involved in pharmacovigilance in Sweden.

Ulfvarson J, Mejyr S, Bergman U.

Pharmacoepidemiol Drug Saf. 2007 May;16(5):532-7.

PMID:
17072915
[PubMed - indexed for MEDLINE]
18.

Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.

Kane-Gill SL, Forsberg EA, Verrico MM, Handler SM.

Drug Saf. 2012 Aug 1;35(8):645-53. doi: 10.2165/11599730-000000000-00000.

PMID:
22720659
[PubMed - indexed for MEDLINE]
19.

Factors associated with preventable adverse drug reactions.

Pearson TF, Pittman DG, Longley JM, Grapes ZT, Vigliotti DJ, Mullis SR.

Am J Hosp Pharm. 1994 Sep 15;51(18):2268-72.

PMID:
7801987
[PubMed - indexed for MEDLINE]
20.

Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.

Lobo MG, Pinheiro SM, Castro JG, Momenté VG, Pranchevicius MC.

BMC Pharmacol Toxicol. 2013 Jan 8;14:5. doi: 10.1186/2050-6511-14-5.

PMID:
23298396
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk